Talaris Therapeutics
Why Robinhood?
You can watch TALS and buy or sell other stocks, ETFs, and their options commission-free!About TALS
Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006.
TALS Key Statistics
Stock Snapshot
As of today, Talaris Therapeutics(TALS) shares are valued at $1.21. The company's market cap stands at 31.04M, with a P/E ratio of -13.97.
On 2026-03-13, Talaris Therapeutics(TALS) stock opened at —, reached a high of —, and a low of —.
The Talaris Therapeutics(TALS)'s current trading volume is 0.
In the last year, Talaris Therapeutics(TALS) shares hit a 52-week high of $48.27 and a 52-week low of $11.56.
In the last year, Talaris Therapeutics(TALS) shares hit a 52-week high of $48.27 and a 52-week low of $11.56.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.